rosiglitazone has been researched along with gw 9578 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, PJ; Henke, BR; Sternbach, DD; Willson, TM | 1 |
Chung, HK; Dong Koo, K; Ho Woo, S; Hur, GC; Joo Yim, H; Kim, GT; Kim, KH; Kim, SH; Lee, CS; Oon Han, H; Sung Koh, J | 1 |
Chen, X; Cryan, E; Demarest, KT; Hlasta, DJ; Matthews, JM; Rybczynski, PJ; Strauss, K; Tang, Y; Xu, JZ; Yang, M; Zhou, L | 1 |
de Lera, AR; Otero, MP; Pérez Santín, E; Rodríguez-Barrios, F; Vaz, B | 1 |
Baatjes, AJ; Campbell, H; Dua, B; Gauvreau, GM; Hill, M; Howie, K; Oliveria, JP; Sehmi, R; Smith, SG; Watson, BM; Watson, RM | 1 |
1 review(s) available for rosiglitazone and gw 9578
Article | Year |
---|---|
The PPARs: from orphan receptors to drug discovery.
Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligands; Models, Molecular; Neoplasms; Nuclear Proteins; Obesity; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2000 |
4 other study(ies) available for rosiglitazone and gw 9578
Article | Year |
---|---|
Design and synthesis of oxime ethers of alpha-acyl-beta-phenylpropanoic acids as PPAR dual agonists.
Topics: Animals; Area Under Curve; Biological Availability; Blood Glucose; Cell Line, Tumor; Drug Design; Humans; Hypoglycemic Agents; Indicators and Reagents; Lipids; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Models, Molecular; Phenylpropionates; PPAR alpha; PPAR gamma; Rosiglitazone; Structure-Activity Relationship; Thiazolidinediones; Triglycerides | 2007 |
Design and synthesis of indane-ureido-thioisobutyric acids: A novel class of PPARalpha agonists.
Topics: Amino Acids; Animals; Butyrates; Combinatorial Chemistry Techniques; Drug Design; Humans; Indans; Mice; Mice, Inbred Strains; Molecular Structure; PPAR alpha; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Urea | 2007 |
Selective, potent PPARgamma agonists with cyclopentenone core structure.
Topics: Cell Line; Computer Simulation; Cyclopentanes; HeLa Cells; Humans; PPAR gamma; Structure-Activity Relationship | 2009 |
Evaluation of peroxisome proliferator-activated receptor agonists on interleukin-5-induced eosinophil differentiation.
Topics: Adolescent; Adult; Aged; Butyrates; Cell Differentiation; Dose-Response Relationship, Drug; Eosinophils; Female; Humans; Interleukin-5; Male; Middle Aged; Peroxisome Proliferator-Activated Receptors; Phenylurea Compounds; Rosiglitazone; Structure-Activity Relationship; Thiazoles; Thiazolidinediones; Young Adult | 2014 |